Abstract:Acetoin, a versatile platform chemical and popular food additive, poses a challenge to the biosafety strain Bacillus subtilis when produced in high concentrations due to its intrinsic toxicity. Incorporating the PHB synthesis pathway into Bacillus subtilis 168 has been shown to significantly enhance the strain's acetoin tolerance. This study aims to elucidate the molecular mechanisms underlying the response of B. subtilis 168- phaCBA to acetoin stress, employing transcriptomic and metabolomic analyses. Acetoin stress induces fatty acid degradation and disrupts amino acid synthesis. In response, B. subtilis 168- phaCBA down-regulates genes associated with flagellum assembly and bacterial chemotaxis, while up-regulating genes related to the ABC transport system encoding amino acid transport proteins. Notably, genes coding for cysteine and d -methionine transport proteins ( tcyB , tcyC and metQ ) and the biotin transporter protein bioY , are up-regulated, enhancing cellular tolerance. Our findings highlight that the expression of phaCBA significantly increases the ratio of long-chain unsaturated fatty acids and modulates intracellular concentrations of amino acids, including l -tryptophan, l -tyrosine, l -leucine, l -threonine, l -methionine, l -glutamic acid, l -proline, d -phenylalanine, l -arginine, and membrane fatty acids, thereby imparting acetoin tolerance. Furthermore, the supplementation with specific exogenous amino acids ( l -alanine, l -proline, l -cysteine, l -arginine, l -glutamic acid, and l -isoleucine) alleviates acetoin's detrimental effects on the bacterium. Simultaneously, the introduction of phaCBA into the acetoin-producing strain BS03 addressed the issue of insufficient intracellular cofactors in the fermentation strain, resulting in the successful production of 70.14 g/L of acetoin through fed-batch fermentation. This study enhances our understanding of Bacillus 's cellular response to acetoin-induced stress and provides valuable insights for the development of acetoin-resistant Bacillus strains.

Progress of Acetoin and its Redox Product Metabolism in Bacteria

Advances in biological production of acetoin: a comprehensive overview

Metabolic Engineering of Zymomonas Mobilis for Acetoin Production by Carbon Redistribution and Cofactor Balance

Mechanism of microbial production of acetoin and 2,3-butanediol optical isomers and substrate specificity of butanediol dehydrogenase

Metabolomics analysis reveals global acetoin stress response of Bacillus licheniformis

Metabolic Engineering of Escherichia coli for High-Level Production of (R)-Acetoin from Low-Cost Raw Materials

The angioarchitecture of colonic diverticula. Significance in bleeding diverticulosis.

Metabolism and strategies for enhanced supply of acetyl-CoA in Saccharomyces cerevisiae

Integrated Intracellular Metabolic Profiling and Pathway Analysis Approaches Reveal Complex Metabolic Regulation by Clostridium Acetobutylicum

Metabolic Engineering ofCorynebacterium Glutamicum for Acetoin Production

Application of Acetate as a Substrate for the Production of Value-Added Chemicals in Escherichia coli

Comparative Expression Profiling of Genes Involved in Primary Metabolism in High-Yield and Wild-Type Strains of Acremonium Chrysogenum

2,3-Butanediol synthesis from glucose supplies NADH for elimination of toxic acetate produced during overflow metabolism

Analysis of heterologous expression of phaCBA promotes the acetoin stress response mechanism in Bacillus subtilis using transcriptomics and metabolomics approaches

Advances in metabolic engineering for enhanced acetyl-CoA availability in yeast

Efficient 2,3-Butanediol/Acetoin Production Using Whole-Cell Biocatalyst with a New Nadh/Nad(+) Regeneration System

Opportunistic diseases.

Use of acetate as substrate for sustainable production of homoserine and threonine by Escherichia coli W3110: A modular metabolic engineering approach

Engineered acetogenic bacteria as microbial cell factory for diversified biochemicals

Microbial acetyl-CoA metabolism and metabolic engineering.

Correction: Corrigendum: Biodegradation-inspired bioproduction of methylacetoin and 2-methyl-2,3-butanediol